top
Please input keywords
Order
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hADAM9 MC38
Common name
B-hADAM9 MC38 Catalog number    322015
Aliases

CORD9, MCMP, MDC9, Mltng

Disease  Colon carcinoma
Organism
Mouse 
Strain  C57BL/6
Tissue types Colon Tissue  Colon
Description 

The exogenous promoter and chimeric ADAM9 coding sequence containing human extracellular domain, mouse transmembrane domain and cytoplasmic domain was inserted to replace murine exon 5-6.

Application

B-hADAM9 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Targeting strategy
from clipboard
Gene targeting strategy for B-hADAM9 MC38 cells. The exogenous promoter and chimeric ADAM9 coding sequence containing human extracellular domain, mouse transmembrane domain and cytoplasmic domain were inserted to replace murine exons 5-6. The insertion disrupts the endogenous murine ADAM9 gene, resulting in a non-functional transcript.

Protein expression analysis 

from clipboard


ADAM9 expression analysis in B-hADAM9 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hADAM9 MC38 cultures were stained with species-specific anti-ADAM9 antibody. Human ADAM9 was detected on the surface of B-hADAM9 MC38 cells but not wild-type MC38 cells. The 1-A05 clone of B-hADAM9 MC38 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

from clipboard


Subcutaneous homograft tumor growth of B-hADAM9 MC38 cells. B-hADAM9 MC38 cells (3x106) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 6-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hADAM9 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.